Skip to main content

Table 1 Characteristics of study participants at baseline (N = 1065)

From: Effectiveness of a diabetes program based on digital health on capacity building and quality of care in type 2 diabetes: a pragmatic quasi-experimental study

Characteristic

n (%)

Me (IQR)

Socio-demographic

 Age in years

N/A

54 (47 – 61)

 Women

657 (61.7%)

N/A

 Married or living with a partner

575 (54%)

N/A

 Less than 12 years of formal education

775 (72.8%)

N/A

 No health insurance

570 (53.5%)

N/A

 Mean age at diabetes diagnosis

N/A

48 (40 – 55)

 Treatment for T2DM

887 (83.3%)

N/A

Medications

 Only oral antidiabetics drugs

750 (70.4%)

N/A

 Only Insulin

42 (3.9%)

N/A

 Insulin + oral antidiabetic drug

95 (8.9%)

N/A

 Calcium channel blocker (amlodipine)

88 (8.3%)

N/A

 Beta blocker (atenolol)

54 (5.1%)

N/A

 ACE inhibitor (enalapril)

446 (41.9%)

N/A

 ACE Inhibitor ARAII (losartan)

109 (10.2%)

N/A

 Diuretics (thiazides or furosemide)

80 (7.5%)

N/A

 Statins (atorvastatin or simvastatin)

179 (16.8%)

N/A

 Aspirin

172 (16.1%)

N/A

Lifestyle

 Smoking#

120 (11.3%)

N/A

 Alcohol consumption#

203 (19.1%)

N/A

 Physical activity#

338 (31.7%)

N/A

 Five or more fruits or vegetables per day#

326 (30.6%)

N/A

Comorbidities

 Hypertension#

648 (60.8%)

N/A

 Dyslipidemia#

350 (32.9%)

N/A

 Overweight /Obesity (BMI ≥ 25)

939 (88.2%)

N/A

Cardiovascular risk*

 Low

369 (34.6%)

N/A

 Moderate

200 (18.8%)

N/A

 High

162 (15.2%)

N/A

 Very high

334 (31%)

N/A

Acute complications

 At least one episode of severe Hypoglycemia #

89 (8.4%)

N/A

Macrovascular chronic complications#

 Stroke

38 (3.6%)

N/A

 Angioplasty, bypass or stent

19 (1.8%)

N/A

 Peripheral arteriopathy

40 (3.8%)

N/A

 Myocardial infarction

32 (3%)

N/A

Microvascular chronic complications#

 Retinopathy, photocoagulation or blindness

111 (10.4%)

N/A

 Chronic kidney disease

24 (2.2%)

N/A

 Peripheral neuropathy or amputation

33 (3.1%)

N/A

Clinical and metabolic profile

 SBP (mmHg)

1055 (99.1%)

130 (120–146.5)

 DBP (mmHg)

1055 (99.1%)

80 (70–90)

 HbA1c (%)

216 (20.3%)

8 (6.9–9.9)

 Fasting blood glucose (mg/dL)

509 (47.8%)

168.59 (128–235)

 Hemoglucotest

180 (16.9%)

184.5 (136- 180)

 Total cholesterol (mg/dL)

387 (36.3%)

194 (160–227.7)

 LDL (mg/dL)

186 (17.5%)

108.50 (79–135)

 HDL (mg/dL)

184 (17.3%)

42.50 (35.5–53.5)

 Triglycerides (mg/dL)

332 (31.2%)

158 (115–231)

 Microalbuminuria (mg/dL)

33 (3.1%)

11.3 (4.3–100)

 Creatinine (mg/dL)

102 (9.6%)

1 (1–1)

  1. #self-reported
  2. *2007 WHO/ISH cardiovascular risk prediction charts for the Americas AMR B; N/A = not applicable; Me = median; IQR = interquartile range